 | • レポートコード：MRC2-11QY12504 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は白血病治療薬のグローバル市場について調査・分析したレポートです。種類別（グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ）市場規模、用途別（病院、研究所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別白血病治療薬の競争状況、市場シェア ・世界の白血病治療薬市場：種類別市場規模 2015年-2020年（グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ） ・世界の白血病治療薬市場：種類別市場規模予測 2021年-2026年（グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ） ・世界の白血病治療薬市場：用途別市場規模 2015年-2020年（病院、研究所、診断センター、その他） ・世界の白血病治療薬市場：用途別市場規模予測 2021年-2026年（病院、研究所、診断センター、その他） ・北米の白血病治療薬市場分析：米国、カナダ ・ヨーロッパの白血病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの白血病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の白血病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの白血病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Pfizer、Novartis AG、Roche、Celgene、Biogen、Genzyme Corporation、Eisai C.、Bristol Myers Squibb Company (BMS) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Leukemia Treatment Drugs is used to cure Leukemia.
Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market.
Market Analysis and Insights: Global Leukemia Treatment Drugs Market
The global Leukemia Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Leukemia Treatment Drugs Scope and Market Size
Leukemia Treatment Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Leukemia Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GSK
Pfizer
Novartis AG
Roche
Celgene
Biogen
Genzyme Corporation
Eisai C.
Bristol Myers Squibb Company (BMS)
Market segment by Type, the product can be split into
Gleevec
Sapacitabine
GA101
Vasaroxine
Tosedosat
Revlimid
Bosutinib
Market segment by Application, split into
Hospitals
Research Institutes
Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Leukemia Treatment Drugs Revenue
1.4 Market by Type
1.4.1 Global Leukemia Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Gleevec
1.4.3 Sapacitabine
1.4.4 GA101
1.4.5 Vasaroxine
1.4.6 Tosedosat
1.4.7 Revlimid
1.4.8 Bosutinib
1.5 Market by Application
1.5.1 Global Leukemia Treatment Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Research Institutes
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Treatment Drugs Market Perspective (2015-2026)
2.2 Global Leukemia Treatment Drugs Growth Trends by Regions
2.2.1 Leukemia Treatment Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Leukemia Treatment Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Leukemia Treatment Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Leukemia Treatment Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Leukemia Treatment Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Treatment Drugs Players by Market Size
3.1.1 Global Top Leukemia Treatment Drugs Players by Revenue (2015-2020)
3.1.2 Global Leukemia Treatment Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Leukemia Treatment Drugs Market Concentration Ratio
3.2.1 Global Leukemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Leukemia Treatment Drugs Revenue in 2019
3.3 Leukemia Treatment Drugs Key Players Head office and Area Served
3.4 Key Players Leukemia Treatment Drugs Product Solution and Service
3.5 Date of Enter into Leukemia Treatment Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Leukemia Treatment Drugs Historic Market Size by Type (2015-2020)
4.2 Global Leukemia Treatment Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Leukemia Treatment Drugs Market Size by Application (2015-2020)
5.2 Global Leukemia Treatment Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Leukemia Treatment Drugs Market Size (2015-2020)
6.2 Leukemia Treatment Drugs Key Players in North America (2019-2020)
6.3 North America Leukemia Treatment Drugs Market Size by Type (2015-2020)
6.4 North America Leukemia Treatment Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Leukemia Treatment Drugs Market Size (2015-2020)
7.2 Leukemia Treatment Drugs Key Players in Europe (2019-2020)
7.3 Europe Leukemia Treatment Drugs Market Size by Type (2015-2020)
7.4 Europe Leukemia Treatment Drugs Market Size by Application (2015-2020)
8 China
8.1 China Leukemia Treatment Drugs Market Size (2015-2020)
8.2 Leukemia Treatment Drugs Key Players in China (2019-2020)
8.3 China Leukemia Treatment Drugs Market Size by Type (2015-2020)
8.4 China Leukemia Treatment Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Leukemia Treatment Drugs Market Size (2015-2020)
9.2 Leukemia Treatment Drugs Key Players in Japan (2019-2020)
9.3 Japan Leukemia Treatment Drugs Market Size by Type (2015-2020)
9.4 Japan Leukemia Treatment Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Leukemia Treatment Drugs Market Size (2015-2020)
10.2 Leukemia Treatment Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Leukemia Treatment Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Leukemia Treatment Drugs Market Size by Application (2015-2020)
11 India
11.1 India Leukemia Treatment Drugs Market Size (2015-2020)
11.2 Leukemia Treatment Drugs Key Players in India (2019-2020)
11.3 India Leukemia Treatment Drugs Market Size by Type (2015-2020)
11.4 India Leukemia Treatment Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Leukemia Treatment Drugs Market Size (2015-2020)
12.2 Leukemia Treatment Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Leukemia Treatment Drugs Market Size by Type (2015-2020)
12.4 Central & South America Leukemia Treatment Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview
13.1.3 GSK Leukemia Treatment Drugs Introduction
13.1.4 GSK Revenue in Leukemia Treatment Drugs Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Leukemia Treatment Drugs Introduction
13.2.4 Pfizer Revenue in Leukemia Treatment Drugs Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Novartis AG
13.3.1 Novartis AG Company Details
13.3.2 Novartis AG Business Overview
13.3.3 Novartis AG Leukemia Treatment Drugs Introduction
13.3.4 Novartis AG Revenue in Leukemia Treatment Drugs Business (2015-2020)
13.3.5 Novartis AG Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Leukemia Treatment Drugs Introduction
13.4.4 Roche Revenue in Leukemia Treatment Drugs Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Celgene
13.5.1 Celgene Company Details
13.5.2 Celgene Business Overview
13.5.3 Celgene Leukemia Treatment Drugs Introduction
13.5.4 Celgene Revenue in Leukemia Treatment Drugs Business (2015-2020)
13.5.5 Celgene Recent Development
13.6 Biogen
13.6.1 Biogen Company Details
13.6.2 Biogen Business Overview
13.6.3 Biogen Leukemia Treatment Drugs Introduction
13.6.4 Biogen Revenue in Leukemia Treatment Drugs Business (2015-2020)
13.6.5 Biogen Recent Development
13.7 Genzyme Corporation
13.7.1 Genzyme Corporation Company Details
13.7.2 Genzyme Corporation Business Overview
13.7.3 Genzyme Corporation Leukemia Treatment Drugs Introduction
13.7.4 Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2015-2020)
13.7.5 Genzyme Corporation Recent Development
13.8 Eisai C.
13.8.1 Eisai C. Company Details
13.8.2 Eisai C. Business Overview
13.8.3 Eisai C. Leukemia Treatment Drugs Introduction
13.8.4 Eisai C. Revenue in Leukemia Treatment Drugs Business (2015-2020)
13.8.5 Eisai C. Recent Development
13.9 Bristol Myers Squibb Company (BMS)
13.9.1 Bristol Myers Squibb Company (BMS) Company Details
13.9.2 Bristol Myers Squibb Company (BMS) Business Overview
13.9.3 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Introduction
13.9.4 Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2015-2020)
13.9.5 Bristol Myers Squibb Company (BMS) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Leukemia Treatment Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Leukemia Treatment Drugs Revenue
Table 3. Ranking of Global Top Leukemia Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Leukemia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gleevec
Table 6. Key Players of Sapacitabine
Table 7. Key Players of GA101
Table 8. Key Players of Vasaroxine
Table 9. Key Players of Tosedosat
Table 10. Key Players of Revlimid
Table 11. Key Players of Bosutinib
Table 12. Global Leukemia Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Leukemia Treatment Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Leukemia Treatment Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Leukemia Treatment Drugs Market Share by Regions (2015-2020)
Table 16. Global Leukemia Treatment Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Leukemia Treatment Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Leukemia Treatment Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Leukemia Treatment Drugs Players
Table 23. Global Leukemia Treatment Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Leukemia Treatment Drugs Market Share by Players (2015-2020)
Table 25. Global Top Leukemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Treatment Drugs as of 2019)
Table 26. Global Leukemia Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Leukemia Treatment Drugs Product Solution and Service
Table 29. Date of Enter into Leukemia Treatment Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Leukemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Leukemia Treatment Drugs Market Size Share by Type (2015-2020)
Table 33. Global Leukemia Treatment Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Leukemia Treatment Drugs Market Size Share by Application (2015-2020)
Table 35. Global Leukemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Leukemia Treatment Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Leukemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Leukemia Treatment Drugs Market Share (2019-2020)
Table 39. North America Leukemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Leukemia Treatment Drugs Market Share by Type (2015-2020)
Table 41. North America Leukemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Leukemia Treatment Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Leukemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Leukemia Treatment Drugs Market Share (2019-2020)
Table 45. Europe Leukemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Leukemia Treatment Drugs Market Share by Type (2015-2020)
Table 47. Europe Leukemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Leukemia Treatment Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Leukemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Leukemia Treatment Drugs Market Share (2019-2020)
Table 51. China Leukemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Leukemia Treatment Drugs Market Share by Type (2015-2020)
Table 53. China Leukemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Leukemia Treatment Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Leukemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Leukemia Treatment Drugs Market Share (2019-2020)
Table 57. Japan Leukemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Leukemia Treatment Drugs Market Share by Type (2015-2020)
Table 59. Japan Leukemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Leukemia Treatment Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Leukemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Leukemia Treatment Drugs Market Share (2019-2020)
Table 63. Southeast Asia Leukemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Leukemia Treatment Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Leukemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Leukemia Treatment Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Leukemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Leukemia Treatment Drugs Market Share (2019-2020)
Table 69. India Leukemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Leukemia Treatment Drugs Market Share by Type (2015-2020)
Table 71. India Leukemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Leukemia Treatment Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Leukemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Leukemia Treatment Drugs Market Share (2019-2020)
Table 75. Central & South America Leukemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Leukemia Treatment Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Leukemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Leukemia Treatment Drugs Market Share by Application (2015-2020)
Table 79. GSK Company Details
Table 80. GSK Business Overview
Table 81. GSK Product
Table 82. GSK Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 83. GSK Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Novartis AG Company Details
Table 90. Novartis AG Business Overview
Table 91. Novartis AG Product
Table 92. Novartis AG Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 93. Novartis AG Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Product
Table 97. Roche Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 98. Roche Recent Development
Table 99. Celgene Company Details
Table 100. Celgene Business Overview
Table 101. Celgene Product
Table 102. Celgene Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 103. Celgene Recent Development
Table 104. Biogen Company Details
Table 105. Biogen Business Overview
Table 106. Biogen Product
Table 107. Biogen Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 108. Biogen Recent Development
Table 109. Genzyme Corporation Company Details
Table 110. Genzyme Corporation Business Overview
Table 111. Genzyme Corporation Product
Table 112. Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 113. Genzyme Corporation Recent Development
Table 114. Eisai C. Business Overview
Table 115. Eisai C. Product
Table 116. Eisai C. Company Details
Table 117. Eisai C. Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 118. Eisai C. Recent Development
Table 119. Bristol Myers Squibb Company (BMS) Company Details
Table 120. Bristol Myers Squibb Company (BMS) Business Overview
Table 121. Bristol Myers Squibb Company (BMS) Product
Table 122. Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2015-2020) (Million US$)
Table 123. Bristol Myers Squibb Company (BMS) Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Treatment Drugs Market Share by Type: 2020 VS 2026
Figure 2. Gleevec Features
Figure 3. Sapacitabine Features
Figure 4. GA101 Features
Figure 5. Vasaroxine Features
Figure 6. Tosedosat Features
Figure 7. Revlimid Features
Figure 8. Bosutinib Features
Figure 9. Global Leukemia Treatment Drugs Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Diagnostic Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Leukemia Treatment Drugs Report Years Considered
Figure 15. Global Leukemia Treatment Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Leukemia Treatment Drugs Market Share by Regions: 2020 VS 2026
Figure 17. Global Leukemia Treatment Drugs Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Leukemia Treatment Drugs Market Share by Players in 2019
Figure 20. Global Top Leukemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Treatment Drugs as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Leukemia Treatment Drugs Revenue in 2019
Figure 22. North America Leukemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Leukemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Leukemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Leukemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Leukemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Leukemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Leukemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
有毛細胞白血病治療の世界市場（～2026年） Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can…- 慢性骨髄性白血病治療の世界市場（～2026年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…
- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 慢性リンパ性白血病（CLL）治療の世界市場（～2026年） Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of monoclonal disorder and is commonly found in adults in western countries. Based on the severity, patients diagnosed with chronic lymphocytic leukemia die wi…
- B細胞慢性リンパ球性白血病治療の世界市場（～2026年） Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global B-Cell Chronic Lymphocy…